Valute / REGN
REGN: Regeneron Pharmaceuticals Inc
554.58
USD
5.87
(1.05%)
Il tasso di cambio REGN ha avuto una variazione del -1.05% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 550.49 e ad un massimo di 563.59.
Segui le dinamiche di Regeneron Pharmaceuticals Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
REGN News
- Zacks Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates
- Zacks Unlocking Q2 Potential of Regeneron (REGN): Exploring Wall Street Estimates for Key Metrics
- Investing Biotech stocks dip as Trump administration mulls patent fee overhaul
- Zacks Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
- The Motley Fool 2 Healthcare Stocks That Are Losing to the S&P 500 This Year
- Zacks Regeneron (REGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
- Zacks REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?
- Seeking Alpha Fidelity OTC Portfolio Q2 2025 Commentary (undefined:FOCPX)
- Seeking Alpha Fidelity Contrafund Q2 2025 Commentary (undefined:FCNTX)
- Zacks Roche Reports 7% 1H25 Sales Growth, Key Drugs Perform Well
- TipRanks QQQ ETF News, 7/24/2025 - TipRanks.com
- Seeking Alpha Longleaf Partners Global Fund Q2 2025 Commentary (LLGLX)
- Benzinga Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - AstraZeneca (NASDAQ:AZN)
- Seeking Alpha Longleaf Partners Fund Q2 2025 Commentary (LLPFX)
- TipRanks QQQ ETF News, 7/22/2025 - TipRanks.com
- The Motley Fool After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
- Zacks Regeneron Stock Plunges 22.6% YTD: Should You Buy, Sell or Hold?
- Investing H.C. Wainwright reiterates Buy rating on Harrow Health stock at $60 target
- TipRanks QQQ ETF News, 7/18/2025 - TipRanks.com
- Zacks BAYRY Skyrockets 62.9% YTD: Should You Buy or Sell the Stock?
- Seeking Alpha Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff (AMGN)
- Investor's Business Daily Stock Market Today: Dow Falls As American Express Tumbles; Advanced Micro Leads Nasdaq Higher (Live Coverage)
- Seeking Alpha AnaptysBio: Potential Promise, But Some Cause For Skepticism (NASDAQ:ANAB)
- Investor's Business Daily Stock Market Holds At Record Highs Despite Trump Tariffs: Weekly Review
Intervallo Giornaliero
550.49
563.59
Intervallo Annuale
476.48
1211.20
- Chiusura Precedente
- 558.14
- Apertura
- 560.45
- Bid
- 554.58
- Ask
- 554.88
- Minimo
- 550.49
- Massimo
- 563.59
- Volume
- 1.001 K
- Variazione giornaliera
- -1.05%
- Variazione Mensile
- 5.84%
- Variazione Semestrale
- -17.09%
- Variazione Annuale
- -48.03%
31 luglio, giovedì
11:30
USD
- Agire
- Fcst
- Prev
- 47.999 K
11:30
USD
- Agire
- Fcst
- -68.3%
- Prev
- -1.6%
12:30
USD
- Agire
- Fcst
- 0.4%
- Prev
- 0.2%
12:30
USD
- Agire
- Fcst
- 2.6%
- Prev
- 2.7%
12:30
USD
- Agire
- Fcst
- 0.2%
- Prev
- 0.1%
12:30
USD
- Agire
- Fcst
- 2.3%
- Prev
- 2.3%
12:30
USD
- Agire
- Fcst
- 0.2%
- Prev
- -0.1%
12:30
USD
- Agire
- Fcst
- 0.7%
- Prev
- -0.4%
12:30
USD
- Agire
- Fcst
- 0.0%
- Prev
- -0.3%
12:30
USD
- Agire
- Fcst
- 0.9%
- Prev
- 0.9%
12:30
USD
- Agire
- Fcst
- 1.0%
- Prev
- 1.2%
12:30
USD
- Agire
- Fcst
- 0.7%
- Prev
- 0.8%
12:30
USD
- Agire
- Fcst
- 224 K
- Prev
- 217 K
12:30
USD
- Agire
- Fcst
- 1.966 M
- Prev
- 1.955 M
12:30
USD
- Agire
- Fcst
- 222.299 K
- Prev
- 224.500 K
13:45
USD
- Agire
- Fcst
- 42.4
- Prev
- 40.4
14:00
USD
- Agire
- Fcst
- 2.3%
- Prev
- 2.0%
14:30
USD
- Agire
- Fcst
- 2 B
- Prev
- 23 B
15:30
USD
- Agire
- Fcst
- Prev
- 4.245%
15:30
USD
- Agire
- Fcst
- Prev
- 4.265%